Dr. Crandall, chiefofthecardiactransplantprogramat the esteemed PalmBeachCardiovascularClinic in Florida, practices on the front lines of interventional, vascular, andtransplantcardiology.
Nissen, who is now the interim chair of cardiology at the Cleveland Clinic and president of the American College of Cardiology, has been at the forefront of doing studies for new heart drugs like AstraZeneca 's Crestor and the new "good cholesterol" drugs being developed by Pfizer.
Steven Nissen, the chairman of cardiology at the Cleveland Clinic and head of the American College of Cardiology, will present one key study that will use ultrasound probes to measure the effect of torcetrapib on plaque in the coronary arteries at the ACC meeting in New Orleans next March.
Nissen, who is now the interim chair of cardiology at the Cleveland Clinic and president of the American College of Cardiology, has been at the forefront of doing studies for new heart drugs like AstraZeneca 's (nyse: AZN - news - people ) Crestor and the new "good cholesterol" drugs being developed by Pfizer (nyse: PFE - news - people ).